Novo Nordisk Plans to Cut Insulin Prices in US by Up to 75%

Drugmaker Novo Nordisk said it would cut list prices for several insulin drugs by up to 75% in the US, starting Jan. 1, 2024.

- Drugmaker Novo Nordisk said on Tuesday it would cut list prices for several insulin drugs by up to 75% in the United States, starting Jan. 1, 2024.

With the move, Novo joins U.S. drugmaker Eli Lilly and Co, which recently said it would cut list prices for its most commonly prescribed insulin products by 70%, beginning from the fourth quarter of this year. High insulin prices by healthcare companies have drawn criticism from lawmakers over the last decade.Novo said it would also reduce the list price of unbranded insulin products to match lowered price of each respective branded insulin.Reuters Health Information © 2023

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | Novo Nordisk to Slash Insulin Prices by Up to 75%Breaking: Novo Nordisk, a large insulin maker, plans to cut the prices of its widely used products up to 75% to make them more affordable for patients. This follows a similar move by Eli Lilly.
Read more »

Novo Nordisk plans to cut insulin prices in U.S. by up to 75%Drugmaker Novo Nordisk said on Tuesday it would cut list prices for several insulin drugs by up to 75% in the United States, starting Jan. 1, 2024.
Read more »

Novo Nordisk Will Cut Insulin Cost in U.S. by Up to 75 PercentNovo Nordisk will slash the list price of several of its insulin drugs by as much as 75 percent, the company said Tuesday.
Read more »

Novo Nordisk plans to cut insulin prices up to 75%, following Eli LillyNovo will reduce the list price for NovoLog and NovoLog Mix 70/30 by 75%, and cut Novolin and Levemir’s list prices by 65% — but not until 2024.
Read more »

Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli LillyNovo Nordisk, along with Sanofi and Eli Lilly, make up most of the U.S. insulin market.
Read more »

Following Eli Lilly, drugmaker Novo Nordisk announces cuts to insulin pricesBREAKING: Novo Nordisk says it will lower the U.S. list price of some of its insulin products by up to 75% starting Jan. 1, 2024, following a similar move by Eli Lilly.
Read more »